More about our sector?

this is your place

Bigfinite Announces Senior Leadership Additions

SAN FRANCISCO, CA – (April 6, 2020) – Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John Vitalie has been named Chief Executive Officer (CEO) and has been elected to the Board of Directors. David Merino has been named Chief Financial Officer (CFO) of Bigfinite. Other recent additions to the Bigfinite leadership team include Crystal Black, VP of Marketing; Cristian Marfà, VP of Technical Sales; and Daniel Voicu, VP of Security.

“John is a first-class executive with a proven track record of success and we’re excited to welcome him to the Bigfinite family,” said Pep Gubau, former CEO and current Executive Chairman and Chief Technology Officer (CTO) of Bigfinite. Gubau will transition from the CEO role he has held for the last five years, since the founding of the company, to the Executive Chairman and retain his role as CTO. “When we started Bigfinite, we had one clear aspiration: to become the market leader in advanced analytics in AI in the pharma and biotech industry. His tremendous experience in sales and accelerated growth will propel us into this new phase of Bigfinite.”

Previously, John Vitalie served as Senior Vice President of NAA CX Sales for Oracle where he led Oracle’s front office application sales and drove several key CX categories while driving higher growth. Before Oracle, John led the entire go-to-market organization as the Senior Vice President of the Healthcare and Life Sciences vertical for North America at Salesforce, Inc. He comes from a strong corporate leadership background including serving as CEO at Precise Software Solutions, President and CEO of Encover, Inc., Corporate Vice President for NASDAQ Stock Exchange and established Siebel Systems as the global market leader of the Life Science Industry as VP of Sales.

“I’m honored to lead this team and to join their mission of helping bring lifesaving drugs to market more quickly, safely and efficiently,” said Vitalie. “Bigfinite has pioneered the application of artificial intelligence, predictive analytics and automation for pharmaceutical and biotech manufacturing processes. We are well positioned to help customers drive their digital transformation while significantly reducing the time to market for their products at a time when this is increasingly important for all stakeholders. Bigfinite is poised for significant growth going forward.”

David MerinoBefore joining Bigfinite as CFO, David Merino was the Managing Director for Novartis Integrated Services Limited, a global service center offering technical and business services to the Global Novartis Manufacturing division after spending five years as part of their Corporate CFO Leadership program. Prior to that, he served as CFO for Novartis Ringaskiddy Limited, one of the largest API manufacturing sites in the Novartis network, driving an ambitious productivity agenda.

“I truly believe Bigfinite’s SaaS platform can drive biotech and pharma manufacturing to new levels of efficiency, quality and regulatory compliance,” said Merino. “I’m excited to be a part of Bigfinite’s new growth phase.”

Other recent additions to the leadership team bring decades of experience in pharma and technology: Crystal Black, VP of Marketing; Cristian Marfà, VP of Technical Sales; and Daniel Voicu, VP of Security.

About Bigfinite, Inc.

Bigfinite is a software provider that transforms manufacturing operations with the use of advanced analytics, artificial intelligence, and pharma 4.0 technologies focused on optimizing pharmaceutical and biotech companies. The Bigfinite analytics platform seamlessly integrates unlimited sources of structured and unstructured data to deliver actionable insights across all manufacturing sites. Bigfinite offers an intuitive way to gain meaningful operational intelligence with data by enabling real-time visibility and predictive insights in a GxP compliant manner with end-to-end data integrity. Founded in 2014, the company is based in San Francisco, California and also has a European office in Barcelona, Spain.

Crystal Black

VP of Marketing

Bigfinite Announces Additions to Executive Team

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that Brian Sweeney, Lawrence Baisch and Glenn Griffin have been added to the leadership team.
Crystal Black VP of Marketing

AI Algorithm Qualification

Pharmaceuticals and Biotech companies have no doubt that Artificial Intelligence (AI) is here to stay. Nonetheless, the opportunities AI technology offers are developing at a slow pace in a rather conservative manufacturing industry, aimed at managing production risks under controls that are subject to strong regulations. Fear of change? Risk aversion? Likely not.
Jordi Guitart VP of Artificial Intelligence

Bigfinite Announces Senior Leadership Additions

Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John Vitalie has been named Chief Executive Officer (CEO) and has been elected to the Board of Directors. David Merino has been named Chief Financial Officer (CFO) of Bigfinite.

Why Biotech and Pharma Need GxP for their Digital Transformation Projects Now

Technological Enhancements with Principal Component Analysis Combined with Artificial Intelligence

Bigfinite Closes Series B Financing with Atlantic Bridge and Honeywell Ventures to Drive Disruption in Manufacturing Analytics

2019 Xavier University AI Summit Reflections – Two Industries Ready for Change

Now that the dust has settled from the Xavier University AI Summit and our team is back to business, we’ve had time to process some of the highlights and key takeaways from the exciting event.  In the past few years, there has been a significant increase in the implementation of digital technologies into various industries that subsequently impacted the way we live, travel, and do business.  From driverless cars to 24/7 customer support chatbots, innovation and technology continue to spiral upward and as we’ve entered the 4th industrial revolution, and healthcare + biopharma should be no exception.  The Xavier University AI Summit is a great event that brings together a range of relevant stakeholders with common focus on artificial intelligence (AI).

Bigfinite and NNE Partnership

Bigfinite and NNE announced a strategic partner program agreement to collaborate around accelerating digital transformation within manufacturing operations at the world's leading pharmaceutical and biotech manufacturers. 

Where are Pharma Companies in the Age of Artificial Intelligence?

They say good things come to those who wait; we say good things come to those who wait but only the things left by the visionaries before them.  The pharmaceutical industry has long been known to lag in the adoption of new technology due to strong regulations. Even though regulators have recently begun to open up to several new ‘big data’ or pharma 4.0 technologies - the question remains, if pharma companies are doing the same?  In 2016, the European Pharmacopoeia 9.0 in Chapter 5.21 announced that neural networks (NN) and support vector machines (SVM) are valid chemometric techniques for processing analytical data sets. 

Data Scientist 4.0 – Bridging the World of Manufacturing and Data

Since the announcement of the 4th Industrial Revolution in 2011, multitudes of emerging technologies have transpired around “Industry 4.0”. Technologies such as digital twins, Industrial Internet of Things (IIoT), and cyber-physical systems have come into the scene as core elements, providing the necessary ingredients for a paradigm shift in manufacturing. Technologies around predictive analytics and artificial intelligence are pioneering new approaches with many use cases including predictive maintenance, autonomous process optimization, and pattern recognition - used to identify potential failures in real-time. Because of this, data science is becoming an invaluable discipline for our industry in order to transform information into knowledge.